CRISPR Technology and Its Impact on the Hemoglobinopathies Market

added blog Health

2025-07-29 08:45:09 -

The global hemoglobinopathies market has seen remarkable advancements in the past decade. Valued at USD 9.63 billion in 2023, the market is forecasted to reach a substantial USD 25.68 billion by 2032, growing at a CAGR of 11.56% from 2024 to 2032. The significant uptick reflects enhanced diagnostic tools, innovative therapies, expanded screening programs, and rising disease awareness across...

0 Comments 0 Shares 143 Views 0 Reviews